E-ISSN: 2619-9467

Contents    Cover    Publication Date: 15 Dec 2023
Year 2023 - Volume 33 - Issue 4

Open Access

Peer Reviewed

ORIGINAL RESEARCH
577 Viewed772 Downloaded

Comparison of the Effectiveness of Pelvic Floor Muscle Training, Biofeedback, and Tibial Nerve Stimulation in Overactive Bladder Syndrome: A Prospective Randomized Controlled Study

Full Text PDF  
JCOG. 2023;33(4):236-44
DOI: 10.5336/jcog.2023-98743
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Objective: It was aimed to comparatively assess the effectiveness of pelvic floor muscle training (PFMT), biofeedback (BF), and transcutaneous tibial nerve stimulation (TTNS) treatments in overactive bladder (OAB) patients. Material and Methods: The patients presented to the urogynecology outpatient clinic between June 2017 and March 2018. They were randomly divided into Group 1: PFMT (n=31), Group 2: PFMT and BF (n=32), and Group 3: PFMT and TTNS (n=33). Patients who received anticholinergic therapy, those who had a previous incontinence surgery or had neurological diseases, those who were pregnant, those who were breastfeeding, those with abnormal liver-kidney functions, persistent urinary infection, or atrophic vaginitis, and those who did not agree to take part in the study were excluded. The OAB Questionnaire (OAB-V8), the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), and the Female Sexual Function Index forms were filled out before and after the 12-week treatment. Results: Daytime and nighttime urinary frequency, total urinary incontinence, and pad test values were lower after the treatment compared to before in all three groups (p<0.001). A statistically significant decline was seen in post-treatment ICIQSF and OAB-V8 scores compared to pre treatment scores in all three groups (p<0.01). The decrease in daytime urinary frequency was seen to be statistically significant in Group 2, and the values in this group were lower compared to those in Groups 1 and 3 (p: 0.045, p: 0.014, respectively). Conclusion: The overall effectiveness of the conservative treatments was determined to be similar. In the selection process, conservative treatment methods should be personalized.
REFERENCES:
  1. Leron E, Weintraub AY, Mastrolia SA, Schwarzman P. Overactive bladder syndrome: evaluation and management. Curr Urol. 2018;11(3):117-25. [Crossref]  [PubMed]  [PMC] 
  2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al; International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4-20. [Crossref]  [PubMed] 
  3. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327-36. [Crossref]  [PubMed] 
  4. Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202(3):558-63. [Crossref]  [PubMed] 
  5. Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10(10):CD005654. [Crossref]  [PubMed]  [PMC] 
  6. Findlay JM, Yeung JM, Robinson R, Greaves H, Maxwell-Armstrong C. Peripheral neuromodulation via posterior tibial nerve stimulation - a potential treatment for faecal incontinence? Ann R Coll Surg Engl. 2010;92(5):385-90. [Crossref]  [PubMed]  [PMC] 
  7. Berghmans LC, Hendriks HJ, De Bie RA, van Waalwijk van Doorn ES, Bø K, van Kerrebroeck PE. Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials. BJU Int. 2000;85(3):254-63. [Crossref]  [PubMed] 
  8. Laycock J, Jerwood D. Pelvic floor muscle assessment: the PERFECT scheme. Physiotherapy. 2001;87(12):631-42. [Crossref] 
  9. Tarcan T, Mangır N, Özgür MÖ, Akbal C. OAB-V8 aşırı aktif mesane sorgulama formu validasyon çalışması [OAB-V8 overactive bladder questionnaire validation study]. Üroloji Bülteni. 2012;21(21):113-6. [Link] 
  10. Çetinel B, Özkan B, Can G. ICIQ-SF Türkçe versiyonu validasyon (geçerlilik) çalışması [The validation study of ICIQ-SF Turkish version]. Turk J Urol. 2004;30(3):332-8. [Link] 
  11. Aydın S, Onaran ÖI, Topalan K, Aydın ÇA, Dansuk R. Development and validation of Turkish version of the Female Sexual Distress Scale-revised. Sex Med. 2016;4(1):e43-50. [Crossref]  [PubMed]  [PMC] 
  12. Kopańska M, Torices S, Czech J, Koziara W, Toborek M, Dobrek Ł. Urinary incontinence in women: biofeedback as an innovative treatment method. Ther Adv Urol. 2020;12:1756287220934359. [Crossref]  [PubMed]  [PMC] 
  13. Firinci S, Yildiz N, Alkan H, Aybek Z. Which combination is most effective in women with idiopathic overactive bladder, including bladder training, biofeedback, and electrical stimulation? A prospective randomized controlled trial. Neurourol Urodyn. 2020;39(8):2498-508. [Crossref]  [PubMed] 
  14. Wang AC, Wang YY, Chen MC. Single-blind, randomized trial of pelvic floor muscle training, biofeedback-assisted pelvic floor muscle training, and electrical stimulation in the management of overactive bladder. Urology. 2004;63(1):61-6. [Crossref]  [PubMed] 
  15. Aukee P, Immonen P, Laaksonen DE, Laippala P, Penttinen J, Airaksinen O. The effect of home biofeedback training on stress incontinence. Acta Obstet Gynecol Scand. 2004;83(10):973-7. [Crossref]  [PubMed] 
  16. Sung MS, Hong JY, Choi YH, Baik SH, Yoon H. FES-biofeedback versus intensive pelvic floor muscle exercise for the prevention and treatment of genuine stress incontinence. J Korean Med Sci. 2000;15(3):303-8. [Crossref]  [PubMed]  [PMC] 
  17. Schmidt AP, Sanches PR, Silva DP Jr, Ramos JG, Nohama P. A new pelvic muscle trainer for the treatment of urinary incontinence. Int J Gynaecol Obstet. 2009;105(3):218-22. [Crossref]  [PubMed] 
  18. Burgio KL, Goode PS, Locher JL, Umlauf MG, Roth DL, Richter HE, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. JAMA. 2002;288(18):2293-9. [Crossref]  [PubMed] 
  19. Voorham JC, De Wachter S, Van den Bos TWL, Putter H, Lycklama À Nijeholt GA, et al. The effect of EMG biofeedback assisted pelvic floor muscle therapy on symptoms of the overactive bladder syndrome in women: a randomized controlled trial. Neurourol Urodyn. 2017;36(7):1796-803. [Crossref]  [PubMed] 
  20. Scaldazza CV, Morosetti C, Giampieretti R, Lorenzetti R, Baroni M. Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study. Int Braz J Urol. 2017;43(1):121-6. [Crossref]  [PubMed]  [PMC] 
  21. Waldinger MD, Schweitzer DH. Persistent genital arousal disorder in 18 Dutch women: Part II. A syndrome clustered with restless legs and overactive bladder. J Sex Med. 2009;6(2):482-97. [Crossref]  [PubMed] 
  22. van Balken MR, Vergunst H, Bemelmans BL. Sexual functioning in patients with lower urinary tract dysfunction improves after percutaneous tibial nerve stimulation. Int J Impot Res. 2006;18(5):470-5 [Crossref]  [PubMed] 
  23. Schreiner L, dos Santos TG, Knorst MR, da Silva Filho IG. Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women. Int Urogynecol J. 2010;21(9):1065-70. [Crossref]  [PubMed] 
  24. Biemans JM, van Balken MR. Efficacy and effectiveness of percutaneous tibial nerve stimulation in the treatment of pelvic organ disorders: a systematic review. Neuromodulation. 2013;16(1):25-33; discussion 33. [Crossref]  [PubMed] 
  25. Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189(6):2194-201. [Crossref]  [PubMed]